Insiders were the key beneficiaries as Mabwell (Shanghai) Bioscience Co., Ltd.’s (SHSE:688062) market cap rises to CN¥12b

Date:

Key Insights

To get a sense of who is truly in control of Mabwell (Shanghai) Bioscience Co., Ltd. (SHSE:688062), it is important to understand the ownership structure of the business. And the group that holds the biggest piece of the pie are individual insiders with 42% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

As a result, insiders were the biggest beneficiaries of last week’s 7.2% gain.

Let’s take a closer look to see what the different types of shareholders can tell us about Mabwell (Shanghai) Bioscience.

View our latest analysis for Mabwell (Shanghai) Bioscience

SHSE:688062 Ownership Breakdown February 29th 2024

What Does The Institutional Ownership Tell Us About Mabwell (Shanghai) Bioscience?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a…

Read more…

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Tampa RV giant Lazydays to delist from Nasdaq

Tampa-based Lazydays Holdings Inc., one of Florida’s most recognized...

Granite Geek: New Hampshire might get access to ‘balcony solar’

I had solar panels put on my roof six...

TSX Today: What to Watch for in Stocks on Monday, November 10

Despite firm gold and silver prices, Canadian stocks...

While BNB and DOT Struggle Under Market Pressure, BlockDAG’s Presale Soars Past $435M!

As market-wide fear grips the sector, the Binance Coin...